Success Story: NIW Approval for an Internal Medicine Resident Advancing Evidence-Based Treatment Strategies

Posted by wegreened on January 30, 2026 in General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry), NIW

Client’s Testimonial:

“Thank you for your services.”

On November 25^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Resident in the field of Medicine (Approval Notice).

General Field: Medicine

Position at the Time of Case Filing: Internal Medicine Resident

Country of Origin: Pakistan

State of Residence at the Time of Filing: New York

Approval Notice Date: November 25^th, 2025

Processing Time: 1 year, 9 months, 11 days (Premium Processing Requested)

Case Summary:

NAILG is pleased to share the approval of an EB-2 NIW petition for a medical researcher dedicated to improving clinical outcomes through standardized, evidence-based treatment plans. At the time of filing, the client held an M.B.B.S. in Medicine and Surgery and had already begun contributing valuable insights across internal medicine, COVID-19 care, and cardiology.

The client’s work addresses some of the most critical health challenges facing the United States today, including cardiovascular disease management, pandemic response, and disparities in treatment outcomes. His proposed endeavor focuses on creating consistent and effective clinical pathways for conditions that place immense strain on healthcare systems. By improving diagnostic accuracy, supporting safer therapeutic choices, and guiding long-term patient management, his research advances national healthcare goals and promotes stronger, more equitable medical practices.

A central strength of this NIW case was the client’s record of meaningful research contributions. He has authored 49 peer-reviewed journal articles, including 12 first-authored papers, and 10 abstracts, covering internal medicine, infectious diseases, cardiology, and public health. His work has accrued 560 citations, demonstrating that fellow researchers around the world rely on his findings to advance their own clinical investigations.

One expert testimonial described his impact succinctly:

“[Client] is a medicine researcher at the highest echelon of our field. He has proven his expertise through his impactful research into internal medicine, particularly in researching novel treatments in cardiology and virology, as well as his prolific publication record in elite academic journals.”

NAILG demonstrated clear and compelling evidence of substantial merit, national importance, and the client’s strong capacity to advance his proposed endeavor, fully satisfying the NIW criteria. His work continues to elevate the understanding of treatment effectiveness and patient management in internal medicine, cardiology, and COVID-19 care. This approval reflects the value of his contributions and supports his ongoing efforts to strengthen healthcare outcomes across the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%